Supporting the premise that aggressive tumor biology leads to worse clinicaloutcomes, we also found the LEE_LIVER_CANCER_SURVIVAL_DN gene signature (comprisedof genes highly expressed in HCC associated with poor survival[27]), to be significantly enriched inthe high AFP class of tumors from our study. This evidence concerns the gene AFP and hepatocellular carcinoma.